Biopharmx Corp Share Price Nyse
Equities
US09072X1019
Biotechnology & Medical Research
Sales 2021 | 887K 70.67M | Sales 2022 | 83.18K 6.63M | Capitalization | 5.2M 415M |
---|---|---|---|---|---|
Net income 2021 | -10M -797M | Net income 2022 | -19M -1.51B | EV / Sales 2021 | 11.5 x |
Net cash position 2021 | 14.05M 1.12B | Net cash position 2022 | 8.75M 697M | EV / Sales 2022 | -42.7 x |
P/E ratio 2021 |
-1.43
x | P/E ratio 2022 |
-0.19
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |